Age at onset as a determinant of presenting phenotype and initial relapse recovery in multiple sclerosis
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background: Age at onset modifies prognosis in multiple sclerosis (MS) and may also exert an effect on the characteristics of disease ignition. Understanding how age influences presentation informs disease management and may allow differentiation of distinct clinical sub-groups. Objectives: To determine the nature of age-specific presentations of relapsing–remitting MS (RRMS) with respect to onset symptoms, gender ratios and index event outcomes. Methods: In a prospective, population-based sample of 1424 patients in South-East Wales we examined associations between age at onset, clinical features and outcome of the onset event, making specific comparisons between paediatric, adolescent and late-onset MS. Results: Age at onset varied significantly between sexes (Male 31.2, Female 29.3, p = 0.002), 0.7% had paediatric onset, 2.7% adolescent onset and 2.8% late-onset MS (>50 years). Optic neuritis was common in younger patients and declined after age 30. Lower limb motor, facial sensory, sexual and sphincteric symptoms rose with age independent of sex and disease course. F:M ratios were highest <16 years of age and declined with increasing age, with a male excess in those over 50. Probability of complete recovery from index event declined with age from 87.4% in the youngest group to 68% in the eldest ( p = 0.009). Conclusions: Age at disease onset in RRMS exerts a significant effect on gender ratios and presenting phenotype, and allows identification of specific clinical sub-groups. In addition, ability to recover from initial relapse declines with age, suggesting accumulation of disability in MS is an age-dependent response to relapse.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Compston, A., & Coles, A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08220-x · Cited by 1,743
Miller, D., Barkhof, F., Montalban, X., Thompson, A., & Filippi, M. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70071-5 · Cited by 594
Clinical characteristics of patients with late-onset multiple sclerosis
Kis, B., Rumberg, B., & Berlit, P. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0778-x · Cited by 137
Cited by
Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes
Ruano, L., Portaccio, E., Goretti, B., Niccolai, C., Severo, M., Patti, F., Cilia, S., Gallo, P., Grossi, P., Ghezzi, A., et al. (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458516674367 · Cited by 331
Ribbons, K. A., McElduff, P., Boz, C., Trojano, M., Izquierdo, G., Duquette, P., Girard, M., Grand’Maison, F., Hupperts, R., Grammond, P., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0122686 · Cited by 190
Aging and Neurodegenerative Disease: Is the Adaptive Immune System a Friend or Foe?
Mayne, K., White, J. A., McMurran, C. E., Rivera, F. J., & de la Fuente, A. G. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.572090 · Cited by 167
Clinical Features of Late-Onset Multiple Sclerosis: a Systematic Review and Meta-analysis
Naseri, A., Nasiri, E., Sahraian, M. A., Daneshvar, S., & Talebi, M. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.102816 · Cited by 142
Garcia-Montojo, M., Dominguez-Mozo, M., Arias-Leal, A., Garcia-Martinez, Á., De las Heras, V., Casanova, I., Faucard, R., Gehin, N., Madeira, A., Arroyo, R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053623 · Cited by 90
“Gender has an impact on various aspects of MS, including age of onset [22], ‘‘parent-of-origin’’ effect on susceptibility [23,24] and risk for relatives of MS patients [25].”
Background
Metadata
- Authors
- Cossburn, M., Ingram, G., Hirst, C., Ben-Shlomo, Y., Pickersgill, T., & Robertson, N.
- Venue
- Multiple Sclerosis Journal
- Publisher
- SAGE Publications
- Published
- 2011-08-24
- Volume
- 18
- Issue
- 1
- Pages
- 45-54
- ISSN
- 1352-4585 (ISSN-L)
- 1477-0970
- OpenAlex
- W2138414141
- Cited by
- 119
- References
- 3
- FWCI
- 3.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Age at onset as a determinant of presenting phenotype and initial relapse recovery in multiple sclerosis. https://app.cochat.ai/papers/10.1177/1352458511417479
- The paper
- Cossburn, M., Ingram, G., Hirst, C., Ben-Shlomo, Y., Pickersgill, T., & Robertson, N. (2012). Age at onset as a determinant of presenting phenotype and initial relapse recovery in multiple sclerosis. Multiple Sclerosis Journal. https://doi.org/10.1177/1352458511417479
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.